A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Washington
Fox Chase Cancer Center
BTG International Inc.
Queen Mary University of London
Brigham and Women's Hospital
Stanford University
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Hellenic Oncology Research Group
University of Chicago
Memorial Sloan Kettering Cancer Center
Northside Hospital, Inc.
Fred Hutchinson Cancer Center